What should you know about Janus kinase inhibitors for rheumatoid arthritis?

Rheumatoid arthritis is an inflammatory condition in which the immune system attacks joint tissues. Janus kinase inhibitors, often called JAK inhibitors, interfere with signalling pathways that help immune cells coordinate inflammation. By reducing that signalling, they may ease joint pain, swelling, and stiffness and help protect day-to-day function. They are disease-modifying medicines, not a quick pain reliever, and the choice depends on your disease activity, previous treatments, infections, other medicines, and general health.

Take the medicine exactly as prescribed and tell your rheumatology team about infections, recent vaccines, pregnancy plans, smoking, blood-clot history, heart or blood-vessel problems, liver disease, and all medicines or supplements. Keep scheduled blood tests and reviews; monitoring may check blood counts, liver function, cholesterol, and signs of infection. Do not start, stop, or combine immune-modifying treatment without advice. Track morning joint stiffness, hand swelling, fatigue, and changes in function so your clinician can assess the response.

Contact your medical team promptly for fever, a persistent cough, painful urination, shingles-like blisters, unusual bruising, or symptoms of a serious infection. Seek emergency care for sudden chest pain, breathlessness, one-sided weakness, severe headache, or a painful swollen leg. New or worsening joint swelling and stiffness may mean the rheumatoid arthritis needs review, even when there are no medicine-related warning signs.

Why is this medicine suitable for my rheumatoid arthritis? What tests are needed before and during treatment? Which infections or symptoms should I report immediately? How will we measure improvement, and what are the alternatives if it does not control my symptoms?